- Interaction between Dietary Factors and Gut Microbiota in Ulcerative Colitis
-
Sung MK
- KMID: 2530346
- J Dig Cancer Res.
- 2022 Jun;10(1):31-38.
- doi: 10.52927/jdcr.2022.10.1.31
Ulcerative colitis (UC) exhibits chronic intestinal inflammatory conditions with cycles of relapse and remission. The incidence is rapidly growing in Asian countries including South Korea possibly due to changes in... -
- CITED
-
- Close
- SHARE
-
- Close
- Pediatric Inflammatory Bowel Disease: A Multicenter Study of Changing Trends in Argentina Over the Past 30 Years
-
Arcucci MS, Contreras MB, Gallo J, Antoniska MA, Busoni V, Tennina C, D’Agostino D, Kakisu MH, Weyersberg C, Orsi M
- KMID: 2529932
- Pediatr Gastroenterol Hepatol Nutr.
- 2022 May;25(3):218-227.
- doi: 10.5223/pghn.2022.25.3.218
Purpose: To analyze the characteristics of pediatric inflammatory bowel disease (IBD) over the past three decades in Argentina and determine if there are differences between the first two decades and... -
- CITED
-
- Close
- SHARE
-
- Close
- The Comparative Risk of Serious Adverse Events With Tofacitinib and TNF Inhibitors in Patients With Ulcerative Colitis: The Korean Experience as Revealed by a National Database
-
Seo GH, Jung SH
- KMID: 2529291
- J Korean Med Sci.
- 2022 Apr;37(16):e123.
- doi: 10.3346/jkms.2022.37.e123
Tofacitinib is an oral, small-molecule Janus kinase inhibitor approved in South Korea for the treatment of moderate to severe ulcerative colitis (UC) on May 1, 2019. However, safety data are... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease
-
Weng MT, Shih IL, Tung CC, Leong YL, Shieh MJ, Wang CY, Wong JM, Ni YH, Wei SC
- KMID: 2529568
- Intest Res.
- 2022 Apr;20(2):224-230.
- doi: 10.5217/ir.2021.00042
Background/Aims: Primary sclerosing cholangitis (PSC) is associated with inflammatory bowel disease (IBD). We aimed to evaluate the prevalence, clinical manifestation, and outcomes of PSC in Taiwanese patients with IBD. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Utility of Fecal Calprotectin in Discriminating Colorectal Polyps From Other Major Etiologies in Children Presenting With Isolated Hematochezia
-
Kim YB, Kim JY, Choi S, Kim HJ, Lee YM, Lee Y, Jang HJ, Lee EH, Lee KJ, Kim SC, Choi SY, Kang Y, Yi DY, Choi YJ, Choe BH, Kang B
- KMID: 2526970
- J Korean Med Sci.
- 2022 Mar;37(9):e72.
- doi: 10.3346/jkms.2022.37.e72
Background: Colorectal polyps are the most common cause of isolated hematochezia in children, which requires a colonoscopy for diagnosis. We aimed to investigate the potential utility of fecal calprotectin (FC)... -
- CITED
-
- Close
- SHARE
-
- Close
- The Use of Transabdominal Ultrasound in Inflammatory Bowel Disease
-
Hata J, Imamura H
- KMID: 2526713
- Korean J Radiol.
- 2022 Mar;23(3):308-321.
- doi: 10.3348/kjr.2021.0692
Transabdominal ultrasound (TAUS) is useful in all aspects of lesion screening, monitoring activity, or treating/diagnosing any related complications of inflammatory bowel disease. Its ability to screen or diagnose complications is... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular characterization of dysplasia-initiated colorectal cancer with assessing matched tumor and dysplasia samples
-
Jung S, Lee JL, Kim TW, Lee J, Yoon YS, Lee KY, Song Kh, Yu CS, Cho YB
- KMID: 2526570
- Ann Coloproctol.
- 2022 Feb;38(1):72-81.
- doi: 10.3393/ac.2021.00290.0041
Purpose: Ulcerative colitis (UC) is known to have an association with the increased risk of colorectal cancer (CRC), and UC-associated CRC does not follow the typical progress pattern of adenoma-carcinoma.... -
- CITED
-
- Close
- SHARE
-
- Close
- Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report
-
Koroku M, Omori T, Kambayashi H, Murasugi S, Kuriyama T, Ikarashi Y, Yonezawa M, Arimura K, Karasawa K, Hanafusa N, Kawana M, Tokushige K
- KMID: 2525082
- Intest Res.
- 2022 Jan;20(1):150-155.
- doi: 10.5217/ir.2020.00148
Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now a pandemic. Although several treatment guidelines have been proposed for patients who have... -
- CITED
-
- Close
- SHARE
-
- Close
- Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
-
Poylin VY, Serrato JC, Pastrana Del Valle J, Feuerstein JD
- KMID: 2525074
- Intest Res.
- 2022 Jan;20(1):72-77.
- doi: 10.5217/ir.2020.00117
Background/Aims: Biologics are increasingly used to manage ulcerative colitis (UC) and Crohn’s disease (CD). However, even with earlier usage of biologic therapy, a significant proportion of patients will require surgery.... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study
-
Sakurai K, Furukawa S, Katsurada T, Otagiri S, Yamanashi K, Nagashima K, Onishi R, Yagisawa K, Nishimura H, Ito T, Maemoto A, Sakamoto N
- KMID: 2525075
- Intest Res.
- 2022 Jan;20(1):78-89.
- doi: 10.5217/ir.2020.00124
Background/Aims: Inflammatory bowel disease (IBD) patients frequently have zinc deficiency. IBD patients with zinc deficiency have higher risks of IBD-related hospitalization, complications, and requiring surgery. This study aimed to examine... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
-
Singh AK, Jena A, Kumar-M P, Jha DK, Sharma V
- KMID: 2525080
- Intest Res.
- 2022 Jan;20(1):134-143.
- doi: 10.5217/ir.2020.00108
Background/Aims: Coronavirus disease 2019 (COVID-19) is recognized to have variable clinical manifestations. The clinical presentation of patients with inflammatory bowel disease (IBD) having COVID-19 is unclear. Methods: We identified articles reporting... -
- CITED
-
- Close
- SHARE
-
- Close
- The dietary practices and beliefs of British South Asian people living with inflammatory bowel disease: a multicenter study from the United Kingdom
-
Crooks B, Misra R, Arebi N, Kok K, Brookes MJ, McLaughlin J, Limdi JK
- KMID: 2525072
- Intest Res.
- 2022 Jan;20(1):53-63.
- doi: 10.5217/ir.2020.00079
Background/Aims: Epidemiological associations have implicated factors associated with Westernization, including the Western diet, in the development of inflammatory bowel disease (IBD). The role of diet in IBD etiopathogenesis, disease control... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study
-
Lee JW, Song EM, Jung SA, Jung SH, Kim KW, Koh SJ, Lee HJ, Hong SW, Park JH, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Park SH, obotIRGotKAftSoID
- KMID: 2523309
- J Korean Med Sci.
- 2021 Dec;36(48):e336.
- doi: 10.3346/jkms.2021.36.e336
In 2020, the novel coronavirus disease 2019 (COVID-19) began to spread worldwide and remains an ongoing medical challenge. This case series reports on the clinical features and characteristics of patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advance in the Management of Dysplasia in the Ulcerative Colitis
-
Yang DH
- KMID: 2522867
- J Dig Cancer Res.
- 2021 Dec;9(2):50-56.
- doi: 10.52927/jdcr.2021.9.2.50
In patients having long-standing ulcerative colitis (UC), the risk of colorectal cancer (CRC) increased compared with general population. Dysplasia is a precancerous lesion of colitic patients, and traditionally total proctocolectomy... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-World Incidence of Suboptimal Response to Anti-Tumor Necrosis Factor Therapy for Ulcerative Colitis: A Nationwide Population-Based Study
-
Shin JY, Park HM, Lee MY, Jeon JY, Yoo HJ, Ye BD
- KMID: 2522348
- Gut Liver.
- 2021 Nov;15(6):867-877.
- doi: 10.5009/gnl20353
Background/Aims: Although anti-tumor necrosis factor (TNF) agents have been widely used to treat ulcerative colitis (UC), the real-world incidence of suboptimal response to anti-TNF agents has not been thoroughly investigated,... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
-
Yu J, Park J, Kang EA, Park SJ, Park JJ, Kim TI, Kim WH, Cheon JH
- KMID: 2522347
- Gut Liver.
- 2021 Nov;15(6):858-866.
- doi: 10.5009/gnl20294
Background/Aims: Few studies have investigated terminal ileal lesions and their prognostic value in patients with ulcerative colitis (UC). We evaluated the clinical significance of these lesions as a prognostic factor... -
- CITED
-
- Close
- SHARE
-
- Close
- Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis
-
Jang HJ, Suh HR, Choi S, Hong SJ, Cho SM, Choi KH, Choe BH, Kang B, on behalf of Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD)
- KMID: 2522358
- J Korean Med Sci.
- 2021 Nov;36(44):e278.
- doi: 10.3346/jkms.2021.36.e278
Background: There are limited data regarding the extraintestinal manifestations (EIMs) associated with pediatric inflammatory bowel disease (IBD) in Korea. We aimed to investigate the clinical features and factors associated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Systematic Review of Recent Lipidomics Approaches Toward Inflammatory Bowel Disease
-
Lee EG, Yoon YC, Yoon J, Lee SJ, Oh YK, Kwon SW
- KMID: 2522246
- Biomol Ther.
- 2021 Nov;29(6):582-595.
- doi: 10.4062/biomolther.2021.125
Researchers have endeavored to identify the etiology of inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis. Though the pathogenesis of inflammatory bowel diseases remains unknown, dysregulation of the immune... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)
-
Hisamatsu T, Kim HJ, Motoya S, Suzuki Y, Ohnishi Y, Fujii N, Matsushima N, Zheng R, Marano CW
- KMID: 2521602
- Intest Res.
- 2021 Oct;19(4):386-397.
- doi: 10.5217/ir.2020.00080
Background/Aims: We aimed to evaluate the efficacy and safety of ustekinumab (UST) in the East-Asian population with moderate to severely active ulcerative colitis (UC). Methods: This sub-analysis was conducted on data... -
- CITED
-
- Close
- SHARE
-
- Close
- Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease
-
Banerjee R, Pal P, Nabi Z, Shava U, Ganesh G, Reddy DN
- KMID: 2521603
- Intest Res.
- 2021 Oct;19(4):398-407.
- doi: 10.5217/ir.2020.00107
Background/Aims: Information on pediatric inflammatory bowel disease (PIBD) and very early onset IBD (VEOIBD) are sparse in India, where IBD is emerging. We aimed to evaluate characteristics of VEOIBD and... -
- CITED
-
- Close
- SHARE
-
- Close
